ARADIGM CORP Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 7 rows in 2007. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2007-12-04: Reporting owner OTULANA BABTUNDE A; Form 4; Security Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2007-12-04: Reporting owner GONDA IGOR; Form 4; Security Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2007-06-20: Reporting owner JAEGER STEPHEN O; Form 4; Security Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2007-06-20: Reporting owner THOMPSON VIRGIL; Form 4; Security Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2007-12-04 | OTULANA BABTUNDE A Officer (VP of Clincal Affairs) | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +100,000 100,000 owned after | $1.60 exercise price | 2007-12-06 | |
| 2007-12-04 | GONDA IGOR Director, Officer (Chief Executive Officer) | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +500,000 500,000 owned after | $1.60 exercise price | 2007-12-06 | |
| 2007-06-20 | JAEGER STEPHEN O Director | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $1.37 exercise price | 2007-06-25 | |
| 2007-06-20 | THOMPSON VIRGIL Director | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +35,000 35,000 owned after | $1.37 exercise price | 2007-06-25 | |
| 2007-06-20 | OTULANA BABTUNDE A Officer (VP of Clincal Affairs) | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $1.37 exercise price | 2007-06-22 | |
| 2007-06-20 | SIEBERT JOHN M Director | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $1.37 exercise price | 2007-06-22 | |
| 2007-06-20 | BARKER FRANK H Director | 4 | Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $1.37 exercise price | 2007-06-22 |